Central autonomic dysfunction affects an estimated 25-76% of patients with acute stroke and is associated with adverse functional outcomes and increased mortality.
Early detection and treatment of central autonomic dysfunction using neuromodulatory and pharmacological interventions may improve survival and recovery in stroke patients.
PURPOSE: Central autonomic dysfunction is common in acute stroke and is associated with cardiovascular complications and increased mortality. The aim of this review is to present novel diagnostic and therapeutic approaches to the management of this disorder and the latest data on its impact on the clinical outcome after stroke. METHODS: We performed a narrative review of recent literature, with a particular focus on articles related to underlying pathophysiological mechanisms of cardiac autonomic dysregulation, the role of cardiac autonomic dysregulation in the activation of neuroinflammatory response and the development of cardiovascular, respiratory and metabolic complications in patients with ischemic and hemorrhagic stroke. RESULTS: The assessment of central autonomic dysfunction by non-invasive diagnostic techniques, including heart rate variability and baroreflex sensitivity, has gained wide practical application in recent years, and they may have a predictive role for evaluating disease prognosis. The emerging evidence derived from recent trials demonstrates that the presence of autonomic imbalance may lead to increased mortality and have an adverse effect on post-stroke rehabilitation. CONCLUSION: The early detection and treatment of central autonomic system dysfunction may lead to improved survival of patients with stroke. Among the available therapeutic approaches, neuromodulatory techniques and pharmacological interventions are promising strategies which may be implemented as part of standard acute stroke care to improve patient recovery. Future studies are warranted to address the long-term effects of potential therapeutic agents on the modulation of cardiovascular autonomic function in stroke survivors.
Barkhudaryan et al. (Tue,) conducted a review in Acute stroke. Central autonomic dysfunction affects an estimated 25-76% of patients with acute stroke and is associated with adverse functional outcomes and increased mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: